A 19-year-old Aboriginal woman from a remote Northern Territory community has a history of definite rheumatic heart disease following acute rheumatic fever at age 12. She is clinically stable with mild mitral regurgitation. What is the recommended regimen for secondary prophylaxis to reduce the risk of recurrent acute rheumatic fever and further valve damage?